Galderma Group AG banner

Intrinsic Value

The intrinsic value of Galderma Group AG (GALDY) under the Base Case is USD per share. Compared with the current market price of 43.65 USD, the stock appears .

The intrinsic value is calculated using the DCF method.

Do our valuations actually work? See backtest results .

GALDY Intrinsic Value

What one share is worth in the bear, base and bull cases.

Create a free account · No card needed

Do our valuations actually work? See backtest results .

Alert me when GALDY is below its intrinsic value
Today Hidden ·
GALDY Valuation History

Intrinsic value next to the price over the past 2 years.

Create a free account · No card needed

Alternatives to GALDY

Fundamental Analysis

What Galderma Group Does

Pharmaceuticals Health Care

Galderma Group AG is a skin-health company that focuses on treatments and products for the skin, face, and body. It sells prescription dermatology medicines, injectable aesthetic treatments, and over-the-counter skin care products. Its portfolio includes products used by dermatologists, medical professionals, and consumers who want help with conditions such as acne, rosacea, eczema, and age-related skin concerns.

Headquarters
Switzerland CH
Employees
7 676
IPO date
Mar 22, 2024
Read the full company overview
View Company Overview
Financials

Balance Sheet

Efficiency

Wall St Price Targets

Shareholder Returns

Competitive Landscape

Recent Events

Latest Earnings Call

Q2 2026 · July 23, 2026

Galderma reported broad first-half momentum, raised its full-year sales outlook and reaffirmed its margin outlook while addressing the Relfydess FDA delay.

Open the earnings call
Stock, next trading day
+2.6%
View Earnings Call

Past 12 months

Continue GALDY Research

Decided on Galderma Group? Get an email when GALDY reaches the price you’d buy at. Free with an account.

Other Galderma Group listings

What is the Intrinsic Value of one GALDY stock?

The intrinsic value for Galderma Group AG (GALDY) under the Base Case is USD.

Is GALDY stock undervalued or overvalued?

Compared with the current market price of 43.65 USD, the stock appears .

How reliable are our estimates? See how past valuations played out
Back to Top